Clinical Trial Update: Pilot Study of CoolTXT for Non-Invasive Fat Reduction [NA]

View source ↗

Summary

A completed pilot trial evaluating CoolTXT, Zeltiq Aesthetics' non-invasive fat reduction technology, in individuals with body fat disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CoolTXT

Snippet

Sponsor: Zeltiq Aesthetics | Conditions: Body Fat Disorder | NA | Status: COMPLETED